explore -WSS

explore

author：fashion 2025-10-01 18:45:40 - browse：917

A page of braille. -- health tech coverage from STAT — Adobe

Katie Keim was diagnosed with type 1 diabetes in 1967 when she was eight, well before the era of insulin pumps or even reliable home testing. The condition started eating away at her vision 20 years later. By the time she was 36, her sight was completely gone.

Keim had lived an independent life as a child despite her illness. Her summers were spent exploring oceans with her family, not at diabetic summer camps. Blindness, though, changed every aspect of her life — including her ability to manage her diabetes. Her first insulin pump had tactile buttons, but all the pumps that came to replace it had digital screens.

“Blind people cannot independently and safely manage our lives through the technology that’s available in home medical devices,” Keim said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Is there really a nursing shortage in the U.S.?

WSS

STAT Readout Newsletter: Biotech news today

Roche drug slashes death risk in early

Cholera vaccine supplies dangerously low, outbreaks surging

Redefining sustainability for the pharmaceutical industry

Redefining sustainability for the pharmaceutical industry

Redefining sustainability for the pharmaceutical industry

entertainment

explore

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

STAT Summit: Meghan O’Rourke on making chronic illness visible

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Readout Newsletter: Beam, Prozac, "TechBio" and more

Trump demands the U.S. pay no more for drugs than other countries … again

Covid overtakes 1918 Spanish flu as deadliest disease in U.S. history

Peter Hotez and the public health issue of online harassment

STAT Summit: Meghan O’Rourke on making chronic illness visible

Medicare details structure of new drug price negotiation program

Readout Newsletter: Beam, Prozac, "TechBio" and more

leisure time

Cholera vaccine supplies dangerously low, outbreaks surging

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

'Vaccine

Smaller biotechs seek to piggyback on weight loss drug boom

Doctor of U.S. President Joe Biden says he is fit for duty

J&J lung cancer data amount to new salvo against AstraZeneca

hotspot

hotspot

focus

knowledge